T-Cell Leukemia：グローバル臨床試験動向（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
T-Cell Leukemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of T-Cell Leukemia to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of T-Cell Leukemia to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of T-Cell Leukemia 24
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in T-Cell Leukemia Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on T-Cell Leukemia 33
Aug 23, 2012: Kyowa Hakko Kirin Initiates Pivotal Phase II Trial Of Mogamulizumab In Patients With Adult T-Cell Leukemia-Lymphoma In US And Europe 33
Apr 09, 2012: Study Demonstrates Potential Of New Anti-Leukemia Compound, Lenaldekar 33
Jan 25, 2012: Study Shows Leukemia Drug Kills Cancerous T-cells While Sparing Normal Immunity 34
Dec 07, 2010: Kyowa Hakko Kirin Announces Results From Japan Phase II Clinical Trial Of KW-0761 In Adult T-Cell Leukemia-Lymphoma 34
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Kirin Holdings Company, Limited 36
Clinical Trial Overview of Kirin Holdings Company, Limited 36
BioCryst Pharmaceuticals, Inc. 37
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 37
Celgene Corporation 38
Clinical Trial Overview of Celgene Corporation 38
Otsuka Holdings Co., Ltd. 39
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Mundipharma International Limited 41
Clinical Trial Overview of Mundipharma International Limited 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Angimmune LLC 43
Clinical Trial Overview of Angimmune LLC 43
Clinical Trial Overview of Top Institutes / Government 44
National Cancer Institute 44
Clinical Trial Overview of National Cancer Institute 44
Fred Hutchinson Cancer Research Center 47
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 47
Ministry of Health, Labour and Welfare, Japan 49
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 49
University of Washington 50
Clinical Trial Overview of University of Washington 50
Japan Clinical Oncology Group 51
Clinical Trial Overview of Japan Clinical Oncology Group 51
Memorial Sloan Kettering Cancer Center 52
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 52
National Heart, Lung, and Blood Institute 53
Clinical Trial Overview of National Heart, Lung, and Blood Institute 53
The University of Texas M. D. Anderson Cancer Center 54
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 54
Washington University School of Medicine 55
Clinical Trial Overview of Washington University School of Medicine 55
Thomas Jefferson University 56
Clinical Trial Overview of Thomas Jefferson University 56
Five Key Clinical Profiles 57
Appendix 122
Abbreviations 122
Definitions 122
Research Methodology 123
Secondary Research 123
About GlobalData 124
Contact Us 124
Disclaimer 124
Source 125